Related Experiment Video
Updated: May 20, 2026

Monitoring Circadian Oscillations with a Bioluminescence Reporter in Organoids
Published on: February 16, 2024
Limosilactobacillus reuteri promotes melatonin release from human intestinal organoids via 5'ectonucleotidase
Micah D Forshee1, Erika J Nachman1, Esha R Shenoy1
1Department of Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA.
Abstract:
Strains of Limosilactobacillus reuteri have been used to prevent or treat various conditions; however, the mechanisms by which they exert beneficial effects are not completely understood. Infant colic is one example in which L. reuteri DSM 17938 reduces clinical symptoms. While the etiology of colic is unknown, abnormal melatonin levels in infants have been suggested as a possible contributor. L. reuteri DSM 17938 has been shown to produce adenosine from AMP via production of the extracellular enzyme 5'ectonucleotidase (5'NT). Adenosine is a potent signaling molecule that impacts several important aspects of host physiology, including the release of melatonin from the pineal gland in the brain. A second major source of melatonin production is enteroendocrine cells in the intestine. We hypothesized that the adenosine generated via the 5'NT activity of L. reuteri DSM 17938, would stimulate melatonin release from human intestinal organoids. Here, we characterized the growth conditions that impact L. reuteri DSM 17938 5'NT activity, including carbon source utilization and required metal cofactors. We found zinc to be an essential cofactor for 5'NT activity by L. reuteri and observed carbon utilization altered 5'NT activity levels. Stachyose and raffinose increased levels of 5'NT activity while sucrose decreased 5'NT activity. We demonstrated that L. reuteri DSM 17938 stimulates melatonin release from pediatric human intestinal organoids in a 5'NT-dependent manner. Surprisingly, adenosine was necessary, but not sufficient, for the induction of epithelial melatonin release, thereby suggesting that an additional secreted factor was also required. Furthermore, L. reuteri BG-R46®, an evolved strain of DSM 17938 that is known to express higher 5'NT activity, was shown to induce higher levels of melatonin secretion. Taken together, this work identifies zinc and carbon sources as key factors altering L. reuteri 5'NT activity levels and demonstrates that the L. reuteri strains stimulate intestinal melatonin release via 5'NT.
Insights
Limosilactobacillus reuteri stimulates intestinal melatonin release through 5'ectonucleotidase (5'NT) activity. This process is influenced by zinc cofactors and specific carbon sources, impacting infant colic treatment.
Area of Science:
- Microbiology
- Gastroenterology
- Pediatrics
Background:
- Limosilactobacillus reuteri strains offer therapeutic benefits, but their mechanisms remain unclear.
- Infant colic is linked to abnormal melatonin levels, and L. reuteri DSM 17938 shows efficacy in reducing symptoms.
- L. reuteri produces adenosine via 5'ectonucleotidase (5'NT), a molecule influencing melatonin release from the brain and intestine.
Purpose of the Study:
- To investigate if L. reuteri DSM 17938-generated adenosine stimulates melatonin release from human intestinal organoids.
- To characterize growth conditions affecting L. reuteri DSM 17938 5'NT activity.
- To determine the role of 5'NT in mediating L. reuteri's effect on intestinal melatonin production.
Main Methods:
- Cultured L. reuteri DSM 17938 under varying carbon sources and metal cofactors to assess 5'NT activity.
- Treated pediatric human intestinal organoids with L. reuteri DSM 17938 and/or adenosine.
- Measured melatonin release from organoids and quantified 5'NT activity in bacterial strains.
Main Results:
- Zinc was identified as an essential cofactor for L. reuteri 5'NT activity.
- Stachyose and raffinose increased 5'NT activity, while sucrose decreased it.
- L. reuteri DSM 17938 stimulated melatonin release from intestinal organoids in a 5'NT-dependent manner, requiring both adenosine and an additional factor.
Conclusions:
- L. reuteri stimulates intestinal melatonin release via 5'NT-dependent mechanisms.
- Zinc and specific dietary carbohydrates are key regulators of L. reuteri 5'NT activity.
- Further research is needed to identify the additional factor required for epithelial melatonin release.
More Related Videos
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
11:04Methods for Electroporation and Transformation Confirmation in Limosilactobacillus reuteri DSM20016
Published on: June 23, 2023
Related Concept Videos
Management of Insomnia
The Pineal Gland
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
Circadian Rhythms and Gene Regulation
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Microbiota of the Large Intestine